Agree that it willdefinitely stop the bleeding. Bu
Post# of 148158
IMHO, these 3 things will attract some institutional investors that are allowed to venture into OTC. There are more than people realize.
Good news is that there is no longer a "short scenario" 'til approval. Then it will be more about marketing & timing.